Integrated personalized diabetes management goes Europe: A multi-disciplinary approach to innovating type 2 diabetes care in Europe

Allan Jones; Jakob Eyvind Bardram; Per Bækgaard; Claus Lundgaard Cramer-Petersen; Timothy Skinner; Karsten Vrangbæk; Laila Starr; Kirsten Nørgaard; Nanna Lind; Merete Bechmann Christensen; Charlotte Glümer; Rui Wang-Sattler; Michael Laxy; Erik Brander; Lutz Heinemann; Tim Heise; Freimut Schliess; Katharina Ladewig; Dagmar Kownatka

doi:10.1016/j.pcd.2020.10.008

Integrated personalized diabetes management goes Europe: A multi-disciplinary approach to innovating type 2 diabetes care in Europe

Allan Jones, Jakob Eyvind Bardram, Per Bækgaard, Claus Lundgaard Cramer-Petersen, Timothy Skinner, Karsten Vrangbæk, Laila Starr, Kirsten Nørgaard, Nanna Lind, Merete Bechmann Christensen, Charlotte Glümer, Rui Wang-Sattler, Michael Laxy, Erik Brander, Lutz Heinemann, Tim Heise, Freimut Schliess, Katharina Ladewig, Dagmar Kownatka

Steno Diabetes Center Copenhagen

14 Citationer (Scopus)

Abstract

Type 2 diabetes mellitus represents a multi-dimensional challenge for European and global societies alike. Building on an iterative six-step disease management process that leverages feedback loops and utilizes commodity digital tools, the PDM-ProValue study program demonstrated that integrated personalized diabetes management, or iPDM, can improve the standard of care for persons living with diabetes in a sustainable way. The novel "iPDM Goes Europe" consortium strives to advance iPDM adoption by (1) implementing the concept in a value-based healthcare setting for the treatment of persons living with type 2 diabetes, (2) providing tools to assess the patient's physical and mental health status, and (3) exploring new avenues to take advantage of emerging big data resources.

Originalsprog	Engelsk
Tidsskrift	Primary Care Diabetes
Vol/bind	15
Udgave nummer	2
Sider (fra-til)	360-364
Antal sider	5
ISSN	1751-9918
DOI	https://doi.org/10.1016/j.pcd.2020.10.008
Status	Udgivet - 1 apr. 2021

Adgang til dokumentet

10.1016/j.pcd.2020.10.008

Andre filer og links

Link to publication in Scopus

Citationsformater

Jones, A., Bardram, J. E., Bækgaard, P., Cramer-Petersen, C. L., Skinner, T., Vrangbæk, K., Starr, L., Nørgaard, K., Lind, N., Bechmann Christensen, M., Glümer, C., Wang-Sattler, R., Laxy, M., Brander, E., Heinemann, L., Heise, T., Schliess, F., Ladewig, K., & Kownatka, D. (2021). Integrated personalized diabetes management goes Europe: A multi-disciplinary approach to innovating type 2 diabetes care in Europe. Primary Care Diabetes, 15(2), 360-364. https://doi.org/10.1016/j.pcd.2020.10.008

Jones, A, Bardram, JE, Bækgaard, P, Cramer-Petersen, CL, Skinner, T, Vrangbæk, K, Starr, L, Nørgaard, K , Lind, N , Bechmann Christensen, M, Glümer, C, Wang-Sattler, R, Laxy, M, Brander, E, Heinemann, L, Heise, T, Schliess, F, Ladewig, K & Kownatka, D 2021, 'Integrated personalized diabetes management goes Europe: A multi-disciplinary approach to innovating type 2 diabetes care in Europe', Primary Care Diabetes, bind 15, nr. 2, s. 360-364. https://doi.org/10.1016/j.pcd.2020.10.008

@article{53c8108df51347f5bde0ea2436a59df1,

title = "Integrated personalized diabetes management goes Europe: A multi-disciplinary approach to innovating type 2 diabetes care in Europe",

abstract = "Type 2 diabetes mellitus represents a multi-dimensional challenge for European and global societies alike. Building on an iterative six-step disease management process that leverages feedback loops and utilizes commodity digital tools, the PDM-ProValue study program demonstrated that integrated personalized diabetes management, or iPDM, can improve the standard of care for persons living with diabetes in a sustainable way. The novel {"}iPDM Goes Europe{"} consortium strives to advance iPDM adoption by (1) implementing the concept in a value-based healthcare setting for the treatment of persons living with type 2 diabetes, (2) providing tools to assess the patient's physical and mental health status, and (3) exploring new avenues to take advantage of emerging big data resources.",

keywords = "Artificial intelligence, Delivery of health care, integrated, Diabetes mellitus, type 2, Patient reported outcome measures, Value-based health insurance",

author = "Allan Jones and Bardram, {Jakob Eyvind} and Per B{\ae}kgaard and Cramer-Petersen, {Claus Lundgaard} and Timothy Skinner and Karsten Vrangb{\ae}k and Laila Starr and Kirsten N{\o}rgaard and Nanna Lind and {Bechmann Christensen}, Merete and Charlotte Gl{\"u}mer and Rui Wang-Sattler and Michael Laxy and Erik Brander and Lutz Heinemann and Tim Heise and Freimut Schliess and Katharina Ladewig and Dagmar Kownatka",

year = "2021",

month = apr,

day = "1",

doi = "10.1016/j.pcd.2020.10.008",

language = "English",

volume = "15",

pages = "360--364",

journal = "Primary Care Diabetes",

issn = "1751-9918",

publisher = "Elsevier BV",

number = "2",

}

TY - JOUR

T1 - Integrated personalized diabetes management goes Europe

T2 - A multi-disciplinary approach to innovating type 2 diabetes care in Europe

AU - Jones, Allan

AU - Bardram, Jakob Eyvind

AU - Bækgaard, Per

AU - Cramer-Petersen, Claus Lundgaard

AU - Skinner, Timothy

AU - Vrangbæk, Karsten

AU - Starr, Laila

AU - Nørgaard, Kirsten

AU - Lind, Nanna

AU - Bechmann Christensen, Merete

AU - Glümer, Charlotte

AU - Wang-Sattler, Rui

AU - Laxy, Michael

AU - Brander, Erik

AU - Heinemann, Lutz

AU - Heise, Tim

AU - Schliess, Freimut

AU - Ladewig, Katharina

AU - Kownatka, Dagmar

PY - 2021/4/1

Y1 - 2021/4/1

N2 - Type 2 diabetes mellitus represents a multi-dimensional challenge for European and global societies alike. Building on an iterative six-step disease management process that leverages feedback loops and utilizes commodity digital tools, the PDM-ProValue study program demonstrated that integrated personalized diabetes management, or iPDM, can improve the standard of care for persons living with diabetes in a sustainable way. The novel "iPDM Goes Europe" consortium strives to advance iPDM adoption by (1) implementing the concept in a value-based healthcare setting for the treatment of persons living with type 2 diabetes, (2) providing tools to assess the patient's physical and mental health status, and (3) exploring new avenues to take advantage of emerging big data resources.

AB - Type 2 diabetes mellitus represents a multi-dimensional challenge for European and global societies alike. Building on an iterative six-step disease management process that leverages feedback loops and utilizes commodity digital tools, the PDM-ProValue study program demonstrated that integrated personalized diabetes management, or iPDM, can improve the standard of care for persons living with diabetes in a sustainable way. The novel "iPDM Goes Europe" consortium strives to advance iPDM adoption by (1) implementing the concept in a value-based healthcare setting for the treatment of persons living with type 2 diabetes, (2) providing tools to assess the patient's physical and mental health status, and (3) exploring new avenues to take advantage of emerging big data resources.

KW - Artificial intelligence

KW - Delivery of health care, integrated

KW - Diabetes mellitus, type 2

KW - Patient reported outcome measures

KW - Value-based health insurance

UR - http://www.scopus.com/inward/record.url?scp=85095835886&partnerID=8YFLogxK

U2 - 10.1016/j.pcd.2020.10.008

DO - 10.1016/j.pcd.2020.10.008

M3 - Review

C2 - 33184011

SN - 1751-9918

VL - 15

SP - 360

EP - 364

JO - Primary Care Diabetes

JF - Primary Care Diabetes

IS - 2

ER -

Integrated personalized diabetes management goes Europe: A multi-disciplinary approach to innovating type 2 diabetes care in Europe

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater